Covid Clot
-
{
- All
- News
- Videos
-
Covid And Other Infections Leave Lasting Impact: Chronic Fatigue, Brain Fog
Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
On "Very Rare" Blood Clots After Covid Jabs, Scientists Now Have More Data
Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting condition following vaccination against COVID-19, according to a study.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
Even Mild Covid Is Linked To Higher Risk of Deadly Blood Clots: Study
Covid-19 at any level of severity is linked to an increased risk of dangerous blood clots that start in patients' veins and travel to the heart, lungs and other parts of the body, according to a UK study
-
Simple Test Can Identify Blood Clots Related To COVID-19: Study
Researchers have used a minimally-invasive test to identify clots in small blood vessels in the skin of patients with severe COVID-19 that appeared normal, according to a study.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Risk Of Serious Clots Up To 6 Months After Covid, Even In Mild Cases: Study
People infected with SARS-CoV-2, the virus that causes COVID-19, have an increased risk of developing serious blood clots for up to six months after the infection, even in mild cases, according to a study published in The BMJ.
-
Covid Increases Risk Of Blood Clots For Up To 6 Months: Study
People who have had Covid-19 have an increased risk of developing serious blood clots for up to six months after getting infected, even in mild cases, a study said Thursday.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Heart Damage Plagues Covid Survivors A Year After Infection, Study Shows
Heart damage from Covid-19 extends well beyond the disease's initial stages, according to a study that found even people who were never sick enough to need hospitalization are in danger of developing heart failure and deadly blood clots a year later.
-
Covid And Other Infections Leave Lasting Impact: Chronic Fatigue, Brain Fog
Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
Covishield Side Effects: Doctors' Group Urges Centre To Review All Covid Vaccines
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine.
-
Supreme Court Agrees To Hear Plea Over Covishield Side-Effect Concern
The Supreme Court will hear a petition on a rare side-effect associated with the COVID vaccine developed jointly by British pharma giant AstraZeneca and Oxford University, manufactured by the Serum Institute of India and sold in India as Covishield.
-
Fact Check: Are Indians Who Got Covishield Vaccine Susceptible To TTS?
AstraZeneca, which developed and manufactured the Covid vaccine Covishield. recently admitted that the vaccine could cause TTS (a condition that may cause blood clots and low platelet count) as a side effect in some people.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
On "Very Rare" Blood Clots After Covid Jabs, Scientists Now Have More Data
Scientists have uncovered more knowledge about the risk of developing a very rare blood clotting condition following vaccination against COVID-19, according to a study.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
Even Mild Covid Is Linked To Higher Risk of Deadly Blood Clots: Study
Covid-19 at any level of severity is linked to an increased risk of dangerous blood clots that start in patients' veins and travel to the heart, lungs and other parts of the body, according to a UK study
-
Simple Test Can Identify Blood Clots Related To COVID-19: Study
Researchers have used a minimally-invasive test to identify clots in small blood vessels in the skin of patients with severe COVID-19 that appeared normal, according to a study.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Risk Of Serious Clots Up To 6 Months After Covid, Even In Mild Cases: Study
People infected with SARS-CoV-2, the virus that causes COVID-19, have an increased risk of developing serious blood clots for up to six months after the infection, even in mild cases, according to a study published in The BMJ.
-
Covid Increases Risk Of Blood Clots For Up To 6 Months: Study
People who have had Covid-19 have an increased risk of developing serious blood clots for up to six months after getting infected, even in mild cases, a study said Thursday.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Heart Damage Plagues Covid Survivors A Year After Infection, Study Shows
Heart damage from Covid-19 extends well beyond the disease's initial stages, according to a study that found even people who were never sick enough to need hospitalization are in danger of developing heart failure and deadly blood clots a year later.
